A carregar...
Original Research: Use of hydroxyurea and phlebotomy in pediatric patients with hemoglobin SC disease
Hydroxyurea is an excellent therapeutic agent for the pharmacological induction of HbF in patients with sickle cell disease (SCD). However, all completed clinical trials of hydroxyurea have excluded patients with hemoglobin SC (HbSC) disease. HbSC differs significantly in pathophysiology from HbSS,...
Na minha lista:
| Publicado no: | Exp Biol Med (Maywood) |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4950384/ https://ncbi.nlm.nih.gov/pubmed/26993671 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1535370216639737 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|